iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
2.820
-0.250 (-8.14%)
At close: Feb 27, 2026, 4:00 PM EST
2.750
-0.070 (-2.48%)
After-hours: Feb 27, 2026, 7:59 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
| 400.00K | 225.00K | | | - | - | - | | | |
Biotechnology (Startups) Growth | 77.78% | - | | | - | - | - | | | |
| - | - | | | -2.32M | -2.46M | -3.46M | | | |
Bioprocessing (Ibio CDMO) | - | - | | | 2.58M | 1.76M | 2.00M | | | |
Bioprocessing (Ibio CDMO) Growth | - | - | | | 46.90% | -11.93% | 300.60% | | | |
Biopharmaceuticals (Ibio, Inc.) | - | - | | | 2.12M | 2.34M | 3.48M | | | |
Biopharmaceuticals (Ibio, Inc.) Growth | - | - | | | -9.58% | -32.85% | 100.63% | | | |
| 400.00K | 225.00K | | | 2.37M | 1.64M | 2.02M | | | |
| 77.78% | - | | | 44.81% | -18.83% | 354.50% | | | |
Source: S&P Global Market Intelligence.
